Clinical Trial Update: A Multi-Arm, Platform Trial For Relapsed Neuroblastoma [Phase 1, Phase 2]

View source ↗

Summary

A multi-arm platform trial for relapsed neuroblastoma spanning Phase 1 and Phase 2 is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: University of Birmingham | Conditions: Relapsed Neuroblastoma | Phase 1, Phase 2 | Status: RECRUITING